ONCY secures U.S. patent for pelareorep manufacturing through 2044

Go back to ONCY secures U.S. patent for pelareorep manufacturing through 2044
Oncolytics Biotech, Inc. (NASDAQ: ONCY) Delayed: 0.95 +0.03 (3.26%)
Previous Close $0.92    52 Week High $1.37 
Open $0.91    52 Week Low $0.24 
Day High $0.96    P/E N/A 
Day Low $0.91    EPS $0.00 
Volume 319,203